Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07221656
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
This study evaluates the median duration of therapeutic serum asparaginase activity (SAA) levels after administration of calaspargase pegol (Cal-PEG) and the potential association between peak SAA levels and duration of therapeutic levels with toxicity in pediatric patients with acute lymphoblastic leukemia or lymphoma.
Key Details
Gender
All
Age Range
Any - 21 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2027-02-01
Completion Date
2028-12-31
Last Updated
2026-04-02
Healthy Volunteers
No
Interventions
OTHER
Non-Interventional Study
Non-interventional study
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States